GenoMed is a Next Generation Disease Managementtm company that uses medical genomics to improve patient outcomes. GenoMed is working to translate knowledge of medical genomics (the study of which genes cause disease) into clinical practice: developing better drugs, using existing drugs for new indications, and identifying diseases before symptoms arise. By studying disease genes, we hope to make medicine less invasive and more proactive.

Patents 1show all

  • 1
    B01D - Separation
  • 1
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry

Contact Information

909 S. Taylor Ave.
St Louis, MO 63110
United States


Total FundingEmployeesLast Funding DateStatus

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2004-07-16$21,000,000Series UnknownPierpoint Investissements